Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease

Val Lowe, Emily S. Lundt, Sabrina M. Albertson, Scott A. Przybelski, Matthew L. Senjem, Joseph E Parisi, Kejal M Kantarci, Bradley F Boeve, David T Jones, David S Knopman, Clifford R Jr. Jack, Dennis W Dickson, Ronald Carl Petersen, Melissa E Murray

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Introduction: Neuroimaging biomarkers are important for early diagnosis of Alzheimer's disease, and comparing multimodality neuroimaging to autopsy data is essential. Methods: We compared the pathologic findings from a prospective autopsy cohort (n = 100)to Pittsburgh compound B PET (PiB-PET), 18F-fluorodeoxyglucose PET (FDG-PET), and MRI. Correlations between neuroimaging biomarkers and neuropathologic schemes were assessed. Results: PiB-PET showed strong correlations with Thal amyloid phase and Consortium to Establish a Registry for Alzheimer's Disease score and categorized 44% of Thal phase 1 participants as positive. FDG-PET and MRI correlated modestly with Braak tangle stage in Alzheimer's type pathology. A subset of participants with “none” or “sparse” neuritic plaque scores had elevated PiB-PET signal due to diffuse amyloid plaque. Participants with findings characterized as “suspected non-Alzheimer's pathophysiology” represented 15% of the group. Discussion: PiB-PET is associated with Alzheimer's disease, neuritic plaques, and diffuse plaques. FDG-PET and MRI have modest correlation with neuropathologic schemes. Participants with findings characterized as suspected non-Alzheimer's pathophysiology most commonly had primary age-related tauopathy.

Original languageEnglish (US)
JournalAlzheimer's and Dementia
DOIs
StatePublished - Jan 1 2019

Fingerprint

Neuroimaging
Neurodegenerative Diseases
Amyloid Plaques
Alzheimer Disease
Autopsy
Biomarkers
Tauopathies
Fluorodeoxyglucose F18
Amyloid
Registries
Early Diagnosis
Pathology
2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole

Keywords

  • Alzheimer's disease
  • Amyloid
  • Amyloid-PET
  • Autopsy
  • Braak tangle stage
  • CERAD
  • Dementia
  • Mild cognitive impairment
  • MRI
  • Neurodegeneration
  • SNAP
  • Tau-PET
  • Thal amyloid stage

ASJC Scopus subject areas

  • Epidemiology
  • Health Policy
  • Developmental Neuroscience
  • Clinical Neurology
  • Geriatrics and Gerontology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

@article{a6b7eeb634c443d3abcbaccd5c16c8e2,
title = "Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease",
abstract = "Introduction: Neuroimaging biomarkers are important for early diagnosis of Alzheimer's disease, and comparing multimodality neuroimaging to autopsy data is essential. Methods: We compared the pathologic findings from a prospective autopsy cohort (n = 100)to Pittsburgh compound B PET (PiB-PET), 18F-fluorodeoxyglucose PET (FDG-PET), and MRI. Correlations between neuroimaging biomarkers and neuropathologic schemes were assessed. Results: PiB-PET showed strong correlations with Thal amyloid phase and Consortium to Establish a Registry for Alzheimer's Disease score and categorized 44{\%} of Thal phase 1 participants as positive. FDG-PET and MRI correlated modestly with Braak tangle stage in Alzheimer's type pathology. A subset of participants with “none” or “sparse” neuritic plaque scores had elevated PiB-PET signal due to diffuse amyloid plaque. Participants with findings characterized as “suspected non-Alzheimer's pathophysiology” represented 15{\%} of the group. Discussion: PiB-PET is associated with Alzheimer's disease, neuritic plaques, and diffuse plaques. FDG-PET and MRI have modest correlation with neuropathologic schemes. Participants with findings characterized as suspected non-Alzheimer's pathophysiology most commonly had primary age-related tauopathy.",
keywords = "Alzheimer's disease, Amyloid, Amyloid-PET, Autopsy, Braak tangle stage, CERAD, Dementia, Mild cognitive impairment, MRI, Neurodegeneration, SNAP, Tau-PET, Thal amyloid stage",
author = "Val Lowe and Lundt, {Emily S.} and Albertson, {Sabrina M.} and Przybelski, {Scott A.} and Senjem, {Matthew L.} and Parisi, {Joseph E} and Kantarci, {Kejal M} and Boeve, {Bradley F} and Jones, {David T} and Knopman, {David S} and Jack, {Clifford R Jr.} and Dickson, {Dennis W} and Petersen, {Ronald Carl} and Murray, {Melissa E}",
year = "2019",
month = "1",
day = "1",
doi = "10.1016/j.jalz.2019.03.016",
language = "English (US)",
journal = "Alzheimer's and Dementia",
issn = "1552-5260",
publisher = "Elsevier Inc.",

}

TY - JOUR

T1 - Neuroimaging correlates with neuropathologic schemes in neurodegenerative disease

AU - Lowe, Val

AU - Lundt, Emily S.

AU - Albertson, Sabrina M.

AU - Przybelski, Scott A.

AU - Senjem, Matthew L.

AU - Parisi, Joseph E

AU - Kantarci, Kejal M

AU - Boeve, Bradley F

AU - Jones, David T

AU - Knopman, David S

AU - Jack, Clifford R Jr.

AU - Dickson, Dennis W

AU - Petersen, Ronald Carl

AU - Murray, Melissa E

PY - 2019/1/1

Y1 - 2019/1/1

N2 - Introduction: Neuroimaging biomarkers are important for early diagnosis of Alzheimer's disease, and comparing multimodality neuroimaging to autopsy data is essential. Methods: We compared the pathologic findings from a prospective autopsy cohort (n = 100)to Pittsburgh compound B PET (PiB-PET), 18F-fluorodeoxyglucose PET (FDG-PET), and MRI. Correlations between neuroimaging biomarkers and neuropathologic schemes were assessed. Results: PiB-PET showed strong correlations with Thal amyloid phase and Consortium to Establish a Registry for Alzheimer's Disease score and categorized 44% of Thal phase 1 participants as positive. FDG-PET and MRI correlated modestly with Braak tangle stage in Alzheimer's type pathology. A subset of participants with “none” or “sparse” neuritic plaque scores had elevated PiB-PET signal due to diffuse amyloid plaque. Participants with findings characterized as “suspected non-Alzheimer's pathophysiology” represented 15% of the group. Discussion: PiB-PET is associated with Alzheimer's disease, neuritic plaques, and diffuse plaques. FDG-PET and MRI have modest correlation with neuropathologic schemes. Participants with findings characterized as suspected non-Alzheimer's pathophysiology most commonly had primary age-related tauopathy.

AB - Introduction: Neuroimaging biomarkers are important for early diagnosis of Alzheimer's disease, and comparing multimodality neuroimaging to autopsy data is essential. Methods: We compared the pathologic findings from a prospective autopsy cohort (n = 100)to Pittsburgh compound B PET (PiB-PET), 18F-fluorodeoxyglucose PET (FDG-PET), and MRI. Correlations between neuroimaging biomarkers and neuropathologic schemes were assessed. Results: PiB-PET showed strong correlations with Thal amyloid phase and Consortium to Establish a Registry for Alzheimer's Disease score and categorized 44% of Thal phase 1 participants as positive. FDG-PET and MRI correlated modestly with Braak tangle stage in Alzheimer's type pathology. A subset of participants with “none” or “sparse” neuritic plaque scores had elevated PiB-PET signal due to diffuse amyloid plaque. Participants with findings characterized as “suspected non-Alzheimer's pathophysiology” represented 15% of the group. Discussion: PiB-PET is associated with Alzheimer's disease, neuritic plaques, and diffuse plaques. FDG-PET and MRI have modest correlation with neuropathologic schemes. Participants with findings characterized as suspected non-Alzheimer's pathophysiology most commonly had primary age-related tauopathy.

KW - Alzheimer's disease

KW - Amyloid

KW - Amyloid-PET

KW - Autopsy

KW - Braak tangle stage

KW - CERAD

KW - Dementia

KW - Mild cognitive impairment

KW - MRI

KW - Neurodegeneration

KW - SNAP

KW - Tau-PET

KW - Thal amyloid stage

UR - http://www.scopus.com/inward/record.url?scp=85066439917&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85066439917&partnerID=8YFLogxK

U2 - 10.1016/j.jalz.2019.03.016

DO - 10.1016/j.jalz.2019.03.016

M3 - Article

JO - Alzheimer's and Dementia

JF - Alzheimer's and Dementia

SN - 1552-5260

ER -